Indian benchmark indices extended losses for a fourth straight session as FII selling and geopolitical concerns hurt sentiment. Amid the we...

Indian stock markets may appear stagnant, but opportunities exist in small and midcap stocks. JM Financial's Ashish Chaturmohta highlights ...

Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...

Laurus Labs Ltd. reached a new record high in May 2026, with experts suggesting the rally will continue. The stock has shown strong upside ...

Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...

Indian indices were subdued with Nifty up 0.03% and Sensex down 0.10%. High volatility (VIX at 19.63) and bearish momentum indicators sugge...

Nifty broke below its 23,800–24,500 consolidation range, signalling near-term weakness, with resistance now seen at 23,800–24,000 and key s...

Laurus Labs Ltd. broke out from a five-month consolidation on monthly charts, reaching fresh record highs in May. Experts suggest short-ter...

Wealthy investors are making significant moves, pouring over $1 billion into ten select stocks. This concentrated buying occurs even as the...

Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...

Investors have a final opportunity today to purchase shares of 10 companies before they go ex-record date for dividends tomorrow, May 8. No...

Laurus Labs surged over 19% in 11 days, hitting a record high of Rs 799.4. Analysts see strong bullish momentum supported by a multi-year b...

Laurus Labs reported a 7% YoY drop in API revenues to Rs 531 crore for Q3 FY24, driven by lower ARV volumes. However, the FDF segment saw A...

Laurus Labs' stock, down over 10% from its 52-week high, shows signs of bottoming out. Analysts suggest a buying opportunity for short-term...

The company attributed this to the change in the effective tax rate for Q1FY23 on account of a drop in SEZ profits exemption u/s 10AA to 50...

Kotak Securities said the acquisition of Richmore would be value accretive for the company, though the incoming revenue is small to impact ...

The stock has rallied 10 per cent over the last one week, and has jumped more than 300 per cent year-to-date.